OxySure responds to FDA O2 system recall

compliance and regulations binders isolated on the office table

OxySure Therapeutics Inc., a medical technology solution company, has issued a response to the US Food and Drug Administration (FDA) organisation after it recalled thousands of the company’s portable oxygen (O2) devices last month.

You must be a subscriber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content today!

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $310.